The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy

International Immunology

Volumn 22, Issue 1, 2009, Pages 1-6

  Taniguchi, Masaru ^a   Tashiro, Takuya ^a   Dashtsoodol, Nyambayar ^a   Hongo, Naomi ^a   Watarai, Hiroshi ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

galactosylceramide; Adjuvant activity; CD1d; INKT cell targeted adjuvant therapy; Invariant V 14J 18

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; CANCER THERAPY; CELL TRANSPLANTATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; INVARIANT NATURAL KILLER T CELL; LUNG CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; ANIMALS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; CYTOTOXICITY, IMMUNOLOGIC; GLYCOLIPIDS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; NATURAL KILLER T-CELLS; NEOPLASMS;

EID: 77949911081     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp104     Document Type: Article

References (62)

1. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H. 2003. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483.
2. - T cells in mice and humans. J. Exp. Med. 180:1097.
3. - T cells. J. Exp. Med. 186:109.
4. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091.
5. + T lymphocytes. Science 268:863.
6. Bendelac, A., Savage, P. B. and Teyton, L. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297.
7. Taniguchi, M., Seino, K. and Nakayama, T. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164.
8. Imai, K., Kanno, M., Kimoto, H. et al. 1986. Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma. Proc. Natl Acad. Sci. USA 83:8708.
9. Koseki, H., Imai, K., Ichikawa, T., Hayata, I. and Taniguchi, M. 1989. Predominant use of a particular alpha-chain in suppressor T cell hybridomas specific for keyhole limpet hemocyanin. Int. Immunol 1:557.
10. + T-cell antigen receptor alpha chain expanded in unprimed mice. Proc. Natl. Acad. Sci. USA 87:5248.
11. + T cell populations. Int. Immunol. 7:1157.
12. + T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 92:1200.
13. Cui, J., Shin, T., Kawano, T. et al. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
14. Fowlkes, B. J., Kruisbeek, A. M., Ton-That, H., Weston, M. A. and Coligan, J. E. 1987. A novel population of T-cell receptor αβ-bearing thymocytes which predominantly expresses a single Vbeta gene family. Nature 329:251.
15. Budd, R. C., Miescher, G. C., Howe, R. C. et al. 1987. Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J. Exp. Med 166:577.
16. Sykes, M. 1990. Unusual T cell populations in adult murine bone marrow. J. Immunol. 145:3209.
17. + thymocytes. J. Immunol. 145:1039.
18. + thymocytes. J. Immunol. 146:1113.
19. - thymocytes with specific lymphokine secretion. Eur. J. Immunol 23:307.
20. Kawano, T., Cui, J., Koezuka, Y. et al. 1997. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278:1626.
21. Borg, N. A., Wun, K. S., Kjer-Nielsen, L. et al. 2007. CD1d-lipidantigen recognition by the semi-invariant NKT T-cell receptor. Nature 448:44.
22. Scott-Browne, J. P., Matsuda, J. L., Mallevaey, T. et al. 2007. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol 8:1105.
23. Pellicci, D. G., Patel, O., Kjer-Nielsen, L. et al. 2009. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 31:47.
24. Mallevaey, T., Scott-Browne, J. P., Matsuda, J. L. et al. 2009. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31:60.
25. Kamada, N., Iijima, H., Kimura, K. et al. 2001. Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Valpha14 NKT cells. Int. Immunol. 13:853.
26. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y. and Casorati, G. 1998. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med 188:1521.
27. + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103:383.
28. Chang, D. H., Osman, K., Connolly, J. et al. 1503. Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J. Exp. Med 201:1503.
29. Motohashi, S. and Nakayama, T. 2008. Clinical applications of natural killer T cell-based immunotherapy for cancer. Cancer Sci. 99:638.
30. Matsuda, J. L., Naidenko, O. V., Gapin, L. et al. 2000. Tracking the response of natural killer Tcells to a glycolipid antigen using CD1d tetramers. J. Exp. Med 192:741.
31. Smiley, S. T., Kaplan, M. H. and Grusby, M. J. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275:977.
32. + Tcell development and early IL-4 production in CD1-deficient mice. Immunity 6:459.
33. Mendiratta, S. K., Martin, W. D., Hong, S. et al. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469.
34. Zhou, D., Mattner, J., Cantu, C. et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786.
35. Speak, A. O., Salio, M., Neville, D. C. et al. 2007. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl Acad. Sci. USA 104:5971.
36. Porubsky, S., Speak, A. O., Luckow, B. et al. 2007. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl Acad. Sci. USA 104:5977.
37. Matsuda, J. L., Gapin, L., Baron, J. L. et al. 2003. Mouse V alpha 14i natural killer Tcells are resistant to cytokine polarization in vivo. Proc. Natl Acad. Sci. USA 100:8395.
38. + NKT cells: stimulation of IL-12 production by antigenpresenting cells in the innate immune system. J. Immunol. 163:93.
39. Kitamura, H., Iwakabe, K., Yahata, T. et al. 1999. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med 189:1121.
40. Trobonjaca, Z., Leithäuser, F., Möller, P., Schirmbeck, R. and Reimann, J. 2001. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J. Immunol 167:1413.
41. + T cells in vivo. J. Immunol. 170:2540.
42. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171:5140.
43. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. and Steinman, R. M. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198:267.
44. Fujii, S., Liu, K., Smith, C., Bonito, A. J. and Steinman, R. M. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607.
45. + natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol. Rev. 220:183.
46. Kojo, S., Seino, K., Harada, M. et al. 2005. Induction of regulatory properties in dendritic cells by Vα14 NKT cells. J. Immunol. 175:3648.
47. neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204:995.
48. - NKT cell population. Proc. Natl Acad. Sci. USA 105:11287.
49. + Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest. 105:1761.
50. Seino, K. I., Fukao, K., Muramoto, K. et al. 2001. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl Acad. Sci. USA 98:2577.
51. Jiang, X., Kojo, S., Harada, M. et al. 2007. Mechanism of NKTcellmediated transplant tolerance. Am. J. Transplant 7:1482.
52. Hong, S., Wilson, M. T., Serizawa, I. et al. 2001. The natural killer Tcell ligand a-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med 7:1052.
53. Sharif, S., Arreaza, G. A., Zucker, P. et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7:1057.
54. Novak, J., Griseri, T., Beaudoin, L. and Lehuen, A. 2007. Regulation of type 1 diabetes by NKT cells. Int. Rev. Immunol. 26:49.
55. + cells mediates early graft loss of syngeneic transplanted islets. J. Exp. Med 202:913.
56. Kawai, T. and Akira, S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317.
57. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4:1230.
58. Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M. et al. 2000. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 97:8461.
59. Toura, I., Kawano, T., Akutsu, Y. et al. 1999. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163:2387.
60. Swann, J., Crowe, N. Y., Hayakawa, Y., Godfrey, D. I. and Smyth, M. J. 2004. Regulation of antitumour immunity by CD1d-restricted NKT cells. Immunol. Cell Biol. 82:323.
61. Motohashi, S., Nagato, K., Kunii, N. et al. 2009. A phase I-II study of α-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J. Immunol. 182:2492.
62. Tashiro, T., Nakagawa, R., Hirokawa, T. et al. 2009. RCAI-56, a carbocyclic analogue of KRN7000: its synthesis and potent activity for natural killer (NK)T cell to preferentially produce interferon-γ. Tetrahedron Lett. 48:3343.